2019
Eligibility for Local Therapies in Adolescents and Adults with Cutaneous Leishmaniasis from Southwestern Colombia: A Cross-Sectional Study.
Uribe-Restrepo AF, Prieto MD, Cossio A, Desai M, Castro M. Eligibility for Local Therapies in Adolescents and Adults with Cutaneous Leishmaniasis from Southwestern Colombia: A Cross-Sectional Study. American Journal Of Tropical Medicine And Hygiene 2019, 100: 306-310. PMID: 30628567, PMCID: PMC6367628, DOI: 10.4269/ajtmh.18-0643.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntimonyAntiprotozoal AgentsChildColombiaCross-Sectional StudiesCryotherapyFemaleHumansHyperthermia, InducedLeishmania braziliensisLeishmania guyanensisLeishmaniasis, CutaneousMaleMiddle AgedParomomycinPentamidinePractice Guidelines as TopicSeverity of Illness IndexConceptsLocal therapyPan American Health OrganizationCutaneous leishmaniasisWorld Health OrganizationIndividualized risk-benefit assessmentCases of CLHealth OrganizationProportion of patientsLarge referral centerRisk-benefit assessmentDifferent treatment guidelinesMaximum lesion sizeReferral centerTreatment guidelinesSystemic drugsWHO criteriaCL patientsSectional studyLeishmania VianniaHigh burdenSevere casesLower riskLesion sizePatientsMild presentation
2015
National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010)
Minges KE, Bikdeli B, Wang Y, Kim N, Curtis JP, Desai MM, Krumholz HM. National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010). The American Journal Of Cardiology 2015, 116: 1436-1442. PMID: 26409636, PMCID: PMC4841688, DOI: 10.1016/j.amjcard.2015.07.068.Peer-Reviewed Original ResearchConceptsHospitalization ratesMortality rateReadmission ratesBlack patientsPrincipal discharge diagnosis codeOlder adultsCause readmission rateHospital mortality rateProportion of patientsRetrospective cohort studyDischarge diagnosis codesSkilled nursing facilitiesNational trendsSignificant racial differencesHigh rateHome health careHospital stayAdults AgedCohort studyMore patientsTherapeutic advancesDiagnosis codesMedicare feeNursing facilitiesSignificant burden
2014
Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
Lampropulos JF, Kim N, Wang Y, Desai MM, Barreto-Filho JA, Dodson JA, Dries DL, Mangi AA, Krumholz HM. Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011. Open Heart 2014, 1: e000109. PMID: 25332817, PMCID: PMC4189322, DOI: 10.1136/openhrt-2014-000109.Peer-Reviewed Original ResearchDischarge dispositionLVAD implantationMortality rateRehospitalisation ratesIndex hospitalisationImplantation rateLeft ventricular assist device useVentricular assist device useMedicaid Services paymentsProportion of patientsLong-term outcomesPost-procedure lengthUse of LVADsDevice implantation ratesHospital daysHospitalisation costsHeartMate IILVAD useMedicare feeMedicare populationMedicare beneficiariesService beneficiariesHospitalisationDevice useStay
2012
Outcomes for Mitral Valve Surgery Among Medicare Fee-for-Service Beneficiaries, 1999 to 2008
Dodson JA, Wang Y, Desai MM, Barreto-Filho JA, Sugeng L, Hashim SW, Krumholz HM. Outcomes for Mitral Valve Surgery Among Medicare Fee-for-Service Beneficiaries, 1999 to 2008. Circulation Cardiovascular Quality And Outcomes 2012, 5: 298-307. PMID: 22576847, PMCID: PMC3400109, DOI: 10.1161/circoutcomes.112.966077.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overChi-Square DistributionFee-for-Service PlansFemaleHealthcare DisparitiesHeart Valve DiseasesHeart Valve Prosthesis ImplantationHospital MortalityHospitalizationHumansLinear ModelsMaleMedicareMitral ValveOdds RatioPatient ReadmissionQuality ImprovementRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeUnited StatesConceptsMitral valve surgeryValve surgeryMitral valve repairFFS patientsHospitalization ratesValve repairMedicare feeMedicare Standard Analytic FilesMedicare FFS patientsRisk-standardized ratesProportion of patientsStandard Analytic FilesVital Status filesNational surveillance dataMedicare administrative dataSubstantial morbidityMortality outcomesService patientsAnalytic FilesMortality riskMortality rateSurgeryPatientsDenominator fileReadmission
2011
Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure
Wong CY, Chaudhry SI, Desai MM, Krumholz HM. Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure. The American Journal Of Medicine 2011, 124: 136-143. PMID: 21295193, PMCID: PMC3237399, DOI: 10.1016/j.amjmed.2010.08.017.Peer-Reviewed Original ResearchConceptsProportion of patientsHeart failureSelf-reported heart failureHeart failure populationComorbid chronic conditionsNumber of comorbiditiesNutrition Examination SurveyCare of patientsPrevalence of disabilityPhenotype of patientsComplexity of patientsMedication useRecent patientsFunctional disabilityExamination SurveyFailure populationPhysical functionPrescription medicationsPatient preferencesChronic conditionsNational HealthPatient's abilityComorbiditiesPatientsOlder individuals